While documenting life on Hawaii’s Big Island, photographer Josh Cogan follows one man’s path toward reconnection—where food, ...
National Geographic photographer Josh Cogan captures the quiet power of Hawaii’s ocean life, revealing how resilience shows ...
VYVGART ® SC is first and only neonatal Fc receptor blocker approved to treat CIDP Authorization is based on global ADHERE study, the largest clinical trial in CIDP to date First novel, targeted ...
Nipocalimab is the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK antibody-positive ...
After being told he might not walk for two years, the longtime Little League football coach fought through treatment to ...
The hybrid CME/CE event featured expert sessions on neurological disorders, emerging technologies, and evidence-based care, strengthening the knowledge and skills of clinicians across the neurology ...
The S&P 1500 Health Care Index advanced 4.0% in the third quarter, underperforming the S&P 500, which gained 8.1%. Read more ...
The S&P 1500 Health Care Index gained 1.9% in September, underperforming the S&P 500, which advanced 3.7%. Read more here.
The previous quarter showed revenue of $396k and a loss of $36.77 million. This valuation on DNTH is abysmal. Price-to-Sales ...
There are two types of inflammation: acute and chronic. Acute inflammation is the kind that lasts a few hours, days, or weeks, and it’s helpful to healing. It’s your immune system’s response when ...
A baby was diagnosed with a brain tumour after he struggled to sit up and use his left hand - symptoms which were initially put down to developmental delays. Jordy Arthur was 10 months old in March, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback